MedPath
HSA Approval

PFIZER BORTEZOMIB POWDER FOR INJECTION 3.5MG

SIN15900P

PFIZER BORTEZOMIB POWDER FOR INJECTION 3.5MG

PFIZER BORTEZOMIB POWDER FOR INJECTION 3.5MG

March 11, 2020

PFIZER PRIVATE LIMITED

PFIZER PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPFIZER PRIVATE LIMITED
Licence HolderPFIZER PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS, SUBCUTANEOUS

Medical Information

L01XX32

xl 01 xx 32

Manufacturer Information

PFIZER PRIVATE LIMITED

Gland Pharma Limited

Active Ingredients

Bortezomib (as a mannitol boronic ester)

3.50mg

Bortezomib

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PFIZER BORTEZOMIB POWDER FOR INJECTION 3.5MG - HSA Approval | MedPath